RAPPORT THERAPEUTICS INC. - COMMON STOCK

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 1 2025 09:12:59 提供 Nasdaq GlobeNewswire

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 1 2025 07:00:00 提供 Nasdaq GlobeNewswire

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

06 12 2024 12:01:00 提供 Nasdaq GlobeNewswire

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

14 11 2024 07:00:02 提供 Nasdaq GlobeNewswire

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

07 11 2024 07:00:01 提供 Nasdaq GlobeNewswire

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

04 11 2024 07:00:00 提供 Nasdaq GlobeNewswire

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

05 9 2024 07:00:00 提供 Nasdaq GlobeNewswire